Meek David D.
Director at QURE; Chief Executive Officer at Mirati Therapeutics, Inc.; Chief Commercial Officer at ENDOCYTE INC
- Sold, on record
- $697k
- Dollars the filings state
- Form 4 sales
- 11
- Latest Jun 11, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- QUREuniQure N.V.Director
- Mirati Therapeutics, Inc.Chief Executive Officer
- ENDOCYTE INCChief Commercial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- QURE10,842 shares
- ENDOCYTE INC10,000 shares
- Mirati Therapeutics, Inc.7,795 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale QUREPlan not statedFeb 28, 2022 2022
Sold 602 shares at $16.70 ($10k)
Meek David D., Director
Sold 7.5% of holdings ($133k position)7,380 shares leftFiling
- 2 Form 4 sale Mirati Therapeutics, Inc.Plan not statedDec 21, 2022 +296 days
Sold 4,616 shares at $40.41 ($187k)
Meek David D., Chief Executive Officer
Sold 6.6% of holdings ($2.8M position)64,971 shares leftFirst sale on recordFiling
- 3 Form 4 sale Mirati Therapeutics, Inc.Plan not statedJan 17, 2023 +27 days
Sold 3,179 shares at $42.38 ($135k)
Meek David D., Chief Executive Officer
Sold 4.9% of holdings ($2.8M position)61,792 shares leftFiling
- 4 Form 4 sale QUREPlan not statedFeb 27, 2023 +41 days
Sold 389 shares at $19.71 ($8k)
Meek David D., Director
Sold 2.4% of holdings ($324k position)16,071 shares leftFiling
- 5 Form 4 sale QURENo planJun 16, 2023 +109 days
Sold 2,290 shares at $18.85 ($43k)
Meek David D., Director
No 10b5-1 planSold 9.2% of holdings ($467k position)22,481 shares leftFiling
- 6 Form 4 sale QURENo planJun 13, 2024 +363 days
Sold 2,229 shares at $5.12 ($11k)
Meek David D., Director
No 10b5-1 planSold 9.9% of holdings ($115k position)20,252 shares leftFiling
- 7 Form 4 sale QURENo planJun 20, 2025 +372 days
Sold 2,112 shares at $14.45 ($31k)
Meek David D., Director
No 10b5-1 planSold 5.8% of holdings ($525k position)34,190 shares leftFiling
- 8 Form 4 sale QURENo planJun 11, 2026 +356 days
Sold 1,993 shares at $27.06 ($54k)
Meek David D., Director
No 10b5-1 planSold 4.8% of holdings ($1.1M position)39,747 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Jun 12, 2026 | QURE | Director | Form 4 sale | 1,993 | $54k | 4.8% | No plan | SEC |
| Jun 20, 2025 | Jun 24, 2025 | QURE | Director | Form 4 sale | 2,112 | $31k | 5.8% | No plan | SEC |
| Jun 13, 2024 | Jun 17, 2024 | QURE | Director | Form 4 sale | 2,229 | $11k | 9.9% | No plan | SEC |
| Jun 16, 2023 | Jun 20, 2023 | QURE | Director | Form 4 sale | 2,290 | $43k | 9.2% | No plan | SEC |
| Feb 27, 2023 | Mar 1, 2023 | QURE | Director | Form 4 sale | 389 | $8k | 2.4% | Plan not stated | SEC |
| Jan 17, 2023 | Jan 19, 2023 | Mirati Therapeutics, Inc. | Chief Executive Officer | Form 4 sale | 3,179 | $135k | 4.9% | Plan not stated | SEC |
| Dec 21, 2022 | Dec 21, 2022 | Mirati Therapeutics, Inc. | Chief Executive Officer | Form 4 sale | 4,616 | $187k | 6.6% | Plan not stated | SEC |
| Feb 28, 2022 | Mar 2, 2022 | QURE | Director | Form 4 sale | 602 | $10k | 7.5% | Plan not stated | SEC |
| Mar 2, 2021 | Mar 4, 2021 | QURE | Director | Form 4 sale | 505 | $19k | 7.3% | Plan not stated | SEC |
| Jan 28, 2020 | Jan 30, 2020 | QURE | Director | Form 4 sale | 722 | $45k | 22.4% | Plan not stated | SEC |
| Sep 12, 2013 | Sep 16, 2013 | ENDOCYTE INC | Chief Commercial Officer | Form 4 sale | 10,000 | $155k | 100.0% | Unusual | SEC |